Eveline Schurink

Eveline Schurink currently serves as the VP of Clinical Development, Patient Safety, and Medical Affairs at Alvotech, a role assumed in January 2022, overseeing a comprehensive pipeline. Prior to this, Schurink held the position of Senior Director of Global Medical Affairs at Alvotech, managing a diverse portfolio of biosimilars in Immunology, Ophthalmology, Osteoporosis, and Oncology. Schurink's experience includes serving as Medical Affairs Lead at Amgen, where responsibilities encompassed multiple therapeutic areas and international engagements. Previous roles include Health Care Consultant at Schurink Consultancy, Board Director at CareCross Health, Health Programme Advisor at UFF Agri Asset Management, Medical Advisor at Pfizer, and Medical Doctor in internal medicine and cardiology at Medisch Centrum Haaglanden. Schurink holds an MPH in Health Economics and Health Systems Management from the University of Liverpool and an M.D. from the University of Groningen.